Research activity per year

Personal profile


- Design of clinical trials according to Good Clinical Practice

- Work in lab: Cell culturing, flowcytometry

- Especially knowledge in malignant melanoma

Main research areas

Oncology: In more detail cancer immunotherapy: The use of a persons immune system to fight cancer; i.e. with monoclonal antibodies, cancer vaccines and T cell therapy. My main research area is to test safety, toxicity an clinical efficacy of peptide vaccines consisting of PD-L1 and IDO peptides in combination with the standard treatment Nivolumab (PD-1 blocking antibody) (first in patient with malignant melanoma, and hopefully expand to other cancer types).

Current research

Clinical trial with the title: "Combination therapy with Nivolumab and PD-L1/IDO peptide vaccine to patients with metastatic melanoma. Inclusion of the first patient in March 2017.

Potential conflicts of interest

No conflicts of interest


Dive into the research topics where Julie Westerlin Kjeldsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or